BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
FRA:BRYN - Deutsche Boerse Ag - US0846707026 - Common Stock - Currency: EUR
Taking everything into account, BRYN scores 4 out of 10 in our fundamental rating. BRYN was compared to 51 industry peers in the Financial Services industry. BRYN has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on BRYN.
1. Profitability
1.1 Basic Checks
In the past year BRYN was profitable.
BRYN had a positive operating cash flow in the past year.
Of the past 5 years BRYN 4 years were profitable.
BRYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRYN has a better Return On Assets (6.95%) than 76.47% of its industry peers.
BRYN has a Return On Equity (12.36%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 4.50%, BRYN is in line with its industry, outperforming 52.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRYN is significantly below the industry average of 11.50%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.50%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.95% | ||
| ROE | 12.36% | ||
| ROIC | 4.5% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
BRYN has a Profit Margin of 21.79%. This is in the better half of the industry: BRYN outperforms 72.55% of its industry peers.
BRYN's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 15.89%, BRYN perfoms like the industry average, outperforming 54.90% of the companies in the same industry.
BRYN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 16.43%, BRYN is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BRYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 21.79% | ||
| GM | 16.43% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
BRYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
Compared to 5 years ago, BRYN has less shares outstanding
BRYN has a better debt/assets ratio than last year.
2.2 Solvency
BRYN has an Altman-Z score of 1.34. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
BRYN has a Altman-Z score of 1.34. This is comparable to the rest of the industry: BRYN outperforms 41.18% of its industry peers.
The Debt to FCF ratio of BRYN is 10.44, which is on the high side as it means it would take BRYN, 10.44 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BRYN (10.44) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.19 indicates that BRYN is not too dependend on debt financing.
The Debt to Equity ratio of BRYN (0.19) is better than 72.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 10.44 | ||
| Altman-Z | 1.34 |
ROIC/WACC1.4
WACC3.22%
2.3 Liquidity
BRYN has a Current Ratio of 1.14. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.14, BRYN is in the better half of the industry, outperforming 60.78% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that BRYN may have some problems paying its short term obligations.
The Quick ratio of BRYN (0.91) is worse than 62.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.77% over the past year.
The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.63% in the past year.
Measured over the past years, BRYN shows a small growth in Revenue. The Revenue has been growing by 7.84% on average per year.
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
3.2 Future
Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 2.26% on average per year.
BRYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.89% yearly.
EPS Next Y-6.03%
EPS Next 2Y-0.06%
EPS Next 3Y1.58%
EPS Next 5Y2.26%
Revenue Next Year-2.41%
Revenue Next 2Y1.33%
Revenue Next 3Y-0.29%
Revenue Next 5Y4.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Earnings ratio.
BRYN is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BRYN to the average of the S&P500 Index (21.76), we can say BRYN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.01 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.06 | ||
| EV/EBITDA | 1.15 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y-0.06%
EPS Next 3Y1.58%
5. Dividend
5.1 Amount
No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (7/11/2025, 7:00:00 PM)
405.05
-3.75 (-0.92%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners33.78%
Inst Owner ChangeN/A
Ins Owners38.2%
Ins Owner ChangeN/A
Market Cap583.27M
Analysts80
Price Target460.55 (13.7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-9.78%
Max EPS beat(2)42.8%
EPS beat(4)2
Avg EPS beat(4)10.96%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)11.15%
EPS beat(12)8
Avg EPS beat(12)9.18%
EPS beat(16)11
Avg EPS beat(16)8.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.05%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-0.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)6
Avg Revenue beat(16)-0.89%
PT rev (1m)-2.38%
PT rev (3m)-5.41%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)-2.32%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)-3.14%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)-3.98%
Revenue NY rev (3m)-2.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.01 | ||
| P/S | 0 | ||
| P/FCF | 0.06 | ||
| P/OCF | 0.02 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 1.15 |
EPS(TTM)27305.19
EY6741.19%
EPS(NY)28206.45
Fwd EY6963.7%
FCF(TTM)7171.51
FCFY1770.52%
OCF(TTM)18384.4
OCFY4538.8%
SpS220696.38
BVpS389021.44
TBVpS318021
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.95% | ||
| ROE | 12.36% | ||
| ROCE | 5.56% | ||
| ROIC | 4.5% | ||
| ROICexc | 4.68% | ||
| ROICexgc | 5.61% | ||
| OM | 15.89% | ||
| PM (TTM) | 21.79% | ||
| GM | 16.43% | ||
| FCFM | 3.25% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 10.44 | ||
| Debt/EBITDA | 1.75 | ||
| Cap/Depr | 145.65% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 11.99 | ||
| Cash Conversion | 42.99% | ||
| Profit Quality | 14.91% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.34 |
F-Score4
WACC3.22%
ROIC/WACC1.4
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
EPS Next Y-6.03%
EPS Next 2Y-0.06%
EPS Next 3Y1.58%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
Revenue Next Year-2.41%
Revenue Next 2Y1.33%
Revenue Next 3Y-0.29%
Revenue Next 5Y4.89%
EBIT growth 1Y12.44%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.83%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-21.13%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%